NR1H4 and metabolic dysfunction-associated steatotic liver disease: Therefore, the activation of FXR by FXR analogues that could prevent de novo lipogenesis, inflammation, and fibrosis may be beneficial in ameliorating NAFLD/MASLD [31,32,33,34,35].